No Data
Volume change rate ranking (9am) - RepliCel, Fujifilm Pharmaceuticals, etc. ranked in.
In the volume change rate ranking, by comparing the volume of the last 5 days with the volume on the delivery day, market participants can understand the trend of the market's interest. Top volume change rate [as of August 19, 9:32am] (compared to the average volume of the last 5 days): stock code, stock name, volume, 5-day average volume, volume change rate, and stock price change rate. <2389> Digital HD, 377200, 107185.08, 241.5%, 0% <488>
Reprocell is ranked in the Alzheimer's disease research paper, and its publication is being considered as important material again.
REPROCELL <4978> is ranked high (as of 9:32am). It is greatly extended. On the 15th, a paper was announced regarding the research on Alzheimer's disease using disease model cells derived from iPS cells developed by REPROCELL and three-dimensional culture substrates (Alvetex) from the group of CSO Stephan Schvoerski (Professor, Department of Biological Sciences, Durham University) of its subsidiary REPROCELL Europe. While it only rose slightly last weekend on the 16th, it is re-evaluated as a material.
Supported by a strong performance and significantly higher US stocks, but there is a heavy resistance to the upward trend.
[Emerging Market Individual Stock Strategy] Today's emerging market is expected to have a solid performance. In the US stock market on the 15th, the Dow Jones Industrial Average rose 554.67 points (+1.39%) to 40,563.06, significantly increasing for the third consecutive day. Concerns about the deterioration of consumption and labor markets have receded due to retail sales and weekly jobless claims. Expectations of a soft landing have increased, and the market has been dominated by buying throughout the day, with the increase expanding towards the end. Today's emerging market is expected to be dominated by buying. In the US stock market yesterday.
ReproCELL: 1st quarter financial results for the March 2025 period (consolidated) based on Japanese standards.
ReproCELL Sees FY Loss Y174.00M
Regil, regional newspapers, etc.
<176A> Shareholding ratio of Regil Co., Ltd. and Mitsui-Communications Co., Ltd.: 8.12% → 9.35%. Reporting obligation date: July 11, 2024. <2164> Shareholding ratio of Chiiki Shimbunsha Co., Ltd. and Milestone Capital Management Co., Ltd.: 12.28% → 12.28%. Reporting obligation date: July 16, 2024. <4431> Shareholding ratio of Takuro Minato in Sumareji Co., Ltd.: 8.39% → 8.05%. Reporting obligation not met.
No Data
